NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES - Nature of Operations (Details) - USD ($) |
6 Months Ended | 12 Months Ended | 41 Months Ended | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
May 29, 2025 |
Apr. 30, 2025 |
Apr. 02, 2025 |
Mar. 27, 2025 |
Feb. 28, 2025 |
Jan. 30, 2025 |
Dec. 31, 2024 |
Dec. 27, 2024 |
Dec. 23, 2024 |
Nov. 27, 2024 |
Oct. 30, 2024 |
Sep. 24, 2024 |
Sep. 19, 2024 |
Aug. 27, 2024 |
Jul. 30, 2024 |
Jun. 26, 2024 |
May 31, 2024 |
May 22, 2024 |
Apr. 29, 2024 |
Mar. 28, 2024 |
Mar. 01, 2024 |
Jan. 30, 2024 |
Dec. 28, 2023 |
Aug. 15, 2023 |
Jul. 31, 2023 |
May 10, 2023 |
Mar. 29, 2023 |
Nov. 07, 2022 |
Sep. 27, 2022 |
Aug. 30, 2022 |
May 11, 2022 |
Jan. 31, 2022 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Jun. 30, 2025 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||||||||||||||||
| Issuance of common shares of beneficial interest (in shares) | 11,127,069 | 11,127,069 | |||||||||||||||||||||||||||||||||||
| Proceeds from issuance of common shares of beneficial interest | $ 6,631,314 | $ 34,960,177 | $ 166,686,437 | ||||||||||||||||||||||||||||||||||
| Proceeds from dividend reinvestment plan | 2,999,482 | ||||||||||||||||||||||||||||||||||||
| Proceeds from contributed capital | 174,696,482 | ||||||||||||||||||||||||||||||||||||
| Capital commitments remain undrawn | $ 106,937,318 | ||||||||||||||||||||||||||||||||||||
| Number of shares repurchased | 22,609 | 132,978 | 373,094 | 528,681 | |||||||||||||||||||||||||||||||||
| Purchase price per share | $ 15.16 | $ 15.04 | $ 15.19 | $ 15.15 | |||||||||||||||||||||||||||||||||
| Asset coverage ratio | 198.00% | 226.00% | 216.00% | ||||||||||||||||||||||||||||||||||
| Capital draw down | |||||||||||||||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||||||||||||||||
| Issuance of common shares of beneficial interest (in shares) | 1,328,901 | 1,310,616 | 667,556 | 341,529 | 1,358,696 | 1,355,013 | 2,333,334 | ||||||||||||||||||||||||||||||
| Proceeds from issuance of common shares of beneficial interest | $ 20,000,000 | $ 20,000,000 | $ 10,000,000 | $ 5,000,000 | $ 20,000,000 | $ 20,000,000 | $ 35,000,000 | $ 130,000,000 | |||||||||||||||||||||||||||||
| Immediate share issuance | |||||||||||||||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||||||||||||||||
| Issuance of common shares of beneficial interest (in shares) | 71,696 | 153,795 | 29,419 | 39,407 | 73,889 | 23,646 | 27,790 | 33,876 | 29,603 | 196,726 | 49,182 | 104,924 | 65,283 | 214,138 | 414,531 | 40,936 | 73,683 | 117,897 | 155,032 | 73,161 | 339,316 | 342,037 | 91,403 | ||||||||||||||
| Proceeds from issuance of common shares of beneficial interest | $ 1,096,001 | $ 2,351,000 | $ 450,000 | $ 600,000 | $ 1,125,000 | $ 360,000 | $ 420,000 | $ 515,000 | $ 450,000 | $ 3,000,000 | $ 750,000 | $ 1,600,000 | $ 1,000,000 | $ 3,280,000 | $ 6,350,000 | $ 625,000 | $ 1,125,000 | $ 1,800,000 | $ 2,350,000 | $ 1,100,000 | $ 5,000,000 | $ 5,000,000 | $ 1,350,000 | $ 41,697,000 | |||||||||||||